Asia Pacific Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity

Asia Pacific pharmaceutical continuous manufacturing market will grow by 12.8% annually with a total addressable market cap of $5,299.8 million over 2020-2030 owing to the rising need for continuous manufacturing process due to cost saving and improved productivity.
Highlighted with 32 tables and 42 figures, this 113-page report “Asia Pacific Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific pharmaceutical continuous manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific pharmaceutical continuous manufacturing market in every aspect of the classification from perspectives of Product, Application, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Integrated Continuous Systems
Semi-Continuous Systems
• Continuous Granulators
• Continuous Blenders
• Continuous Compressors
• Continuous Coaters
• Continuous Dryers
• Other Semi-Continuous Systems
Controls & Software

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
End Product Manufacturing
• Solid Dosage Manufacturing
• Liquid Dosage Manufacturing
API Manufacturing

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Pharmaceutical Companies
• Contract Manufacturing Organizations
• Research Organizations and Institutes
• Other End Users

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
Detailed analysis and 2019-2030 annual revenue are available for each key national market. The breakdown of key national markets by Product, Technology, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific pharmaceutical continuous manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrüder Lödige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter’s Fiver Forces Analysis 35
3 Segmentation of Asia Pacific Market by Product 41
3.1 Market Overview by Product 41
3.2 Integrated Continuous Systems 43
3.3 Semi-Continuous Systems 44
3.3.1 Continuous Granulators 46
3.3.2 Continuous Blenders 47
3.3.3 Continuous Compressors 48
3.3.4 Continuous Coaters 49
3.3.5 Continuous Dryers 50
3.3.6 Other Semi-Continuous Systems 51
3.4 Controls & Software 52
4 Segmentation of Asia Pacific Market by Application 53
4.1 Market Overview by Application 53
4.2 End Product Manufacturing 55
4.2.1 Solid Dosage Manufacturing 57
4.2.2 Liquid Dosage Manufacturing 58
4.3 API Manufacturing 59
5 Segmentation of Asia Pacific Market by End User 61
5.1 Market Overview by End User 61
5.2 Pharmaceutical Companies 63
5.3 Contract Manufacturing Organizations 64
5.4 Research Organizations and Institutes 65
5.5 Other End Users 66
6 Asia-Pacific Market 2019-2030 by Country 67
6.1 Overview of Asia-Pacific Market 67
6.2 Japan 70
6.3 China 73
6.4 Australia 76
6.5 India 78
6.6 South Korea 80
6.7 Rest of APAC Region 82
7 Competitive Landscape 84
7.1 Overview of Key Vendors 84
7.2 New Product Launch, Partnership, Investment, and M&A 87
7.3 Company Profiles 88
ACG Group 88
Alexanderwerk 90
Baker Perkins Ltd. 91
Coperion GmbH 92
Fette Compacting 93
Freund-vector Corporation 94
GEA Group AG 95
Gebrüder Lödige Maschinenbau GmbH 96
Gericke AG 97
Glatt GmbH 98
Hosokawa Micron Corporation 99
Korsch AG 100
Leistritz AG 101
Munson Machinery Company, Inc. 102
Powrex Corp 103
Scott Equipment Company 104
Sturtevant, Inc. 105
Thermo Fisher Scientific Inc. 106
8 Investing in Asia Pacific Market: Risk Assessment and Management 107
8.1 Risk Evaluation of Asia Pacific Market 107
8.2 Critical Success Factors (CSFs) 110
Related Reports and Products 113

Key Players (this may not be a complete list and extra companies can be added upon request):
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrüder Lödige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
Table 1. Snapshot of Asia Pacific Pharmaceutical Continuous Manufacturing Market, 2019-2030 18
Table 2. Growth Rate of World Real GDP, 2017-2021 21
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Pharmaceutical Continuous Manufacturing Market 31
Table 4. Asia Pacific Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 41
Table 5. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems by Type, 2019-2030, $ mn 45
Table 6. Asia Pacific Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 53
Table 7. Asia Pacific Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing by Type, 2019-2030, $ mn 56
Table 8. Asia Pacific Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 61
Table 9. APAC Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn 68
Table 10. Japan Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 72
Table 11. Japan Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 72
Table 12. Japan Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 72
Table 13. China Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 75
Table 14. China Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 75
Table 15. China Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 75
Table 16. Australia Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 77
Table 17. Australia Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 77
Table 18. Australia Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 77
Table 19. India Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 79
Table 20. India Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 79
Table 21. India Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 79
Table 22. South Korea Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 81
Table 23. South Korea Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 81
Table 24. South Korea Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 81
Table 25. Pharmaceutical Continuous Manufacturing Market in Rest of APAC by Country, 2019-2030, $ mn 83
Table 26. ACG Group: Company Snapshot 88
Table 27. ACG Group: Business Segmentation 88
Table 28. ACG Group: Product Portfolio 89
Table 29. ACG Group: Revenue, 2016-2018, $ mn 89
Table 30. ACG Group: Recent Developments 89
Table 31. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030 108
Table 32. Critical Success Factors and Key Takeaways 111
Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. Asia Pacific Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn 19
Figure 6. Impact of COVID-19 on Business 23
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Pharmaceutical Continuous Manufacturing Market 25
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Pharmaceutical Continuous Manufacturing Market 28
Figure 9. Investment Opportunity Analysis 32
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Pharmaceutical Continuous Manufacturing Market 35
Figure 11. Breakdown of Asia Pacific Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, % of Sales Revenue 41
Figure 12. Asia Pacific Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%) 42
Figure 13. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Integrated Continuous Systems, 2019-2030, $ mn 43
Figure 14. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems, 2019-2030, $ mn 44
Figure 15. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Granulators, 2019-2030, $ mn 46
Figure 16. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Blenders, 2019-2030, $ mn 47
Figure 17. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Compressors, 2019-2030, $ mn 48
Figure 18. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Coaters, 2019-2030, $ mn 49
Figure 19. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Dryers, 2019-2030, $ mn 50
Figure 20. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Other Semi-Continuous Systems, 2019-2030, $ mn 51
Figure 21. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Controls & Software, 2019-2030, $ mn 52
Figure 22. Breakdown of Asia Pacific Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, % of Sales Revenue 54
Figure 23. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 54
Figure 24. Asia Pacific Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing, 2019-2030, $ mn 55
Figure 25. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Solid Dosage Manufacturing, 2019-2030, $ mn 57
Figure 26. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Liquid Dosage Manufacturing, 2019-2030, $ mn 58
Figure 27. Asia Pacific Pharmaceutical Continuous Manufacturing Market: API Manufacturing, 2019-2030, $ mn 59
Figure 28. Breakdown of Asia Pacific Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, % of Revenue 62
Figure 29. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 62
Figure 30. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Pharmaceutical Companies, 2019-2030, $ mn 63
Figure 31. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Contract Manufacturing Organizations, 2019-2030, $ mn 64
Figure 32. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Research Organizations and Institutes, 2019-2030, $ mn 65
Figure 33. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Other End Users, 2019-2030, $ mn 66
Figure 34. Breakdown of APAC Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue 68
Figure 35. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 69
Figure 36. Pharmaceutical Continuous Manufacturing Market in Japan, 2019-2030, $ mn 71
Figure 37. Pharmaceutical Continuous Manufacturing Market in China, 2019-2030, $ mn 74
Figure 38. Pharmaceutical Continuous Manufacturing Market in Australia, 2019-2030, $ mn 76
Figure 39. Pharmaceutical Continuous Manufacturing Market in India, 2019-2030, $ mn 78
Figure 40. Pharmaceutical Continuous Manufacturing Market in South Korea, 2019-2030, $ mn 80
Figure 41. Pharmaceutical Continuous Manufacturing Market in Rest of APAC, 2019-2030, $ mn 82
Figure 42. Growth Stage of Asia Pacific Pharmaceutical Continuous Manufacturing Industry over the Forecast Period 84

Frequently Asked Questions About This Report

Choose License Type

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

Our Clients

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.